Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ

BACKGROUND: Endocrine therapy is commonly recommended in the adjuvant setting for patients as treatment for ductal carcinoma in situ (DCIS). However, it is unknown whether a neoadjuvant (preoperative) anti-estrogen approach to DCIS results in any biological change. This study was undertaken to inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yunn-Yi, DeVries, Sandy, Anderson, Joseph, Lessing, Juan, Swain, Rebecca, Chin, Koei, Shim, Veronica, Esserman, Laura J, Waldman, Frederic M, Hwang, E Shelley
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744704/
https://www.ncbi.nlm.nih.gov/pubmed/19689789
http://dx.doi.org/10.1186/1471-2407-9-285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2744704/
https://www.ncbi.nlm.nih.gov/pubmed/19689789
http://dx.doi.org/10.1186/1471-2407-9-285

Ejemplares similares